Newborn Screening Market Growth Rate, Overview, Price Analysis Of Top Manufactures Profiles And Fore

By Author: Dittya
Total Articles: 16
Comment this article

The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research. Newborn screening tests in infants check for developmental, metabolic, and genetic abnormalities. Newborn screening includes more than 30 illnesses and conditions. Additionally, various governmental and non-profit agencies are primarily focusing on providing quality fetal and maternal care.
Besides, the industry is expected to experience a boost in demand due to the involvement of federal bodies involved in coordinating awareness and quality control programs to imbibe confidence and low the number of deaths caused by negligence and non-screening. New treatments such as enzyme replacement therapy, hematopoietic stem cell transplant, gene therapy, and novel therapeutic drugs have allowed the inclusion of autoimmune disorders as possible candidates in NBS programs.
Read more@ https://www.emergenresearch.com/industry-report/new-born-screening-market
Based on the in-depth analysis the research also brings to light major facts pertaining to the vital aspects such as market share, size, ...
... and growth rate. Deep dive into other aspects including the investment feasibility, demand and supply, import and export status, supply chain management and growth prospects narrates a lot about what the business environment will be like for the forecast period,2020 - 2027. All the vital statistics in the report are explained with the help of resources such as tables, charts, and info graphics.
Key Highlights From The Report
Based on the technology, electrophoresis generated a revenue of USD 0.15 billion in 2019 and is predicted to rise with a CAGR of 11.1% in the forecast period owing to the increasing demand and new detection techniques that assist in recognition of amino acids, carnitine conjugates, and other compounds.
The assay kits are expected to grow with a CAGR of 10.4% in the forecasted period, attributable to its wide variety of classes such as enzymatic assay kits, DNA assay kits, immunoassay kits, and others of which immunoassay is a process-oriented used in the screening.
The dry blood spot test application is the major contributor to the Newborn Screening Market. The dry blood spot test application of the North America region is the major shareholder of the market and held around 43.1% of the market in the year 2019.
North America dominated the market with a share of 34.7% in 2019 due to its adoption of cost-effective and innovative procedures.
Newborn Screening Market Key participants include Bio-Rad Laboratories Inc., Agilent Technologies Inc., Trivitron Healthcare, Natus Medical Inc., PerkinElmer Inc., AB Sciex LLC, Covidien Plc, Masimo Corp., GE Healthcare, and Waters Corp., among others.
Request for free sample@ https://www.emergenresearch.com/request-sample/4
Newborn Screening Market Technology Outlook (Revenue, USD Billion; 2017-2027)
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others
Newborn Screening Market Product Outlook (Revenue, USD Billion; 2017-2027)
Instruments
Reagents
Assay Kits
Others
Newborn Screening Market Application Outlook (Revenue, USD Billion; 2017-2027)
Dry Blood Spot Test
Critical Congenital Heart Disease (CCHD)
Hearing Screen
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. Newborn Screening Market Definition
1.2. Newborn Screening Market Research Scope
1.3. Newborn Screening Market Methodology
1.4. Newborn Screening Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Newborn Screening Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Newborn Screening Market Segmentation & Impact Analysis
Continued…